Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292352 · ClinicalTrials.gov registry record · NA
Prevention of NAFLD in Hispanic Children
A NA study of Non-alcoholic Fatty Liver Disease, sponsored by Emory University.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT05292352 is a NA study of Non-alcoholic Fatty Liver Disease that is active but no longer recruiting, run by Emory University. The registered enrollment target is 103 participants, below the 188-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05292352, a NA study of Non-alcoholic Fatty Liver Disease, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
Conditions Studied
Interventions
- BEHAVIORAL LFSD
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05292352
The ClinicalTrials.gov registry entry for NCT05292352 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (45% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which LFSD is the first listed.
NCT05292352 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05292352 about?
NCT05292352 is a clinical study titled "Prevention of NAFLD in Hispanic Children". This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
What is the current status of trial NCT05292352?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2022-04-06. Estimated completion is 2027-03-31.
What conditions does trial NCT05292352 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT05292352?
The interventions under investigation include: LFSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05292352?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292352 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.